United Kingdom

Allena Pharmaceuticals Inc (ALNA.OQ)

ALNA.OQ on NASDAQ Stock Exchange Global Select Market

22 Feb 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Allena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II... (more)


No Ratios Available.


  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-HBM BioCapital II reports 7.94 pct passive stake in Allena Pharma

* HBM BioCapital II LP reports 7.94 percent passive stake in Allena Pharmaceuticals Inc as of November 6, 2017 - SEC filing‍​ Source text: (http://bit.ly/2A4iWbx) Further company coverage:

16 Nov 2017

BRIEF-Allena Pharmaceuticals shares open 14.3 pct below IPO price in debut

* Allena Pharmaceuticals shares open at $12 in debut on the NASDAQ versus IPO price of $14/shr‍​ Further company coverage:

02 Nov 2017

IFR Americas ECM Pipeline

Allena Pharmaceuticals (US, biotech) – $74.6m IPO. 5.33m shares (100% prim) at $14.00 versus $14-$16 marketing. CS, JEFF, COWN. Algonquin Power & Utilities (Canada, utility) – C$500m Block. 37.8m shares (100% prim) at C$13.25 versus C$13.75 last sale. SCOT, CIBC, TD. Assembly Biosciences (US, biotech) – $60m ABB. 2.2m shares (100% prim) at $27.25, versus $27.25-$27.75 marketing and $28.58 last sale. JEFF, WMB. Evoqua Water Holdings (US, water services) – $500m IPO. 27.8m shares (100% prim) at $1

02 Nov 2017

BRIEF-Allena Pharmaceuticals prices IPO of 5.3 mln shares at $14 per share

* Allena pharmaceuticals, Inc. Announces pricing of initial public offering

02 Nov 2017

BRIEF-Allena Pharmaceuticals sees IPO price range of $14-$16/shr

* Allena pharmaceuticals Inc sees IPO of up to 5.33 million shares‍​ of common stock to be priced between $14 and $16 per share - SEC filing‍​ Source text: [http://bit.ly/2zvbZf3] Further company coverage:

23 Oct 2017

Earnings vs. Estimates